Troy A. Ignelzi
CIK 1579829 · Chief Financial Officer · last filed 2026-10-21
Troy A. Ignelzi is a Chief Financial Officer who has filed 47 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing shows the insider bought $143.6K of RAPP on Oct 21, 2026. Across all open-market trades the lifetime net is −$25.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $403.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
KRTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
46701 COMMERCE CENTER DRIVE
PLYMOUTH, MI 48170
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Chief Financial Officer | 15,500 | $26.04 | $403.6K | $244.5K | 5 | 2026-10-21 |
| CTNM | Director | — | $10.84 | — | $0 | 4 | 2026-06-26 |
| HRMY | Director | — | $33.36 | — | $0 | 1 | 2026-04-06 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Chief Financial Officer | 31,907 | $329.83 | $10.52M | -$25.79M | 29 | 2023-08-24 |
| CinCor Pharma, Inc. (CINC) Delisted | Director | — | $29.06 | — | $0 | 1 | 2023-02-24 |
| scPharmaceuticals Inc. (SCPH) Delisted | Chief Financial Officer | — | $5.67 | — | $0 | 1 | 2018-01-19 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-21 | RAPP | Buy (P) | +5,500 | $143.6K | EDGAR |
| 2026-06-26 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2026-04-06 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2026-02-04 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2025-03-13 | RAPP | Buy (P) | +10,000 | $101.0K | EDGAR |
| 2025-02-04 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2024-05-20 | CTNM | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.